<DOC>
	<DOC>NCT00811577</DOC>
	<brief_summary>The purpose of this study was to determine the safety of AZX100 Drug Product and to determine whether it was effective in preventing or reducing scars that were made from trocars following arthroscopic shoulder surgery.</brief_summary>
	<brief_title>A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients</brief_title>
	<detailed_description />
	<criteria>Scheduled for an arthroscopic shoulder surgery that will result in at least 3 trocar sites Healthy male or nonpregnant female 1875 years old Nondiabetic Body Mass Index 1835 No clinically significant abnormal values on blood test Nonsmoker for previous 6 months History of acute or chronic disease Cancer within previous 5 years, except for removed skin cancer Hypersensitivity reaction Allergy to general anesthesia, lidocaine, or epinephrine Current skin disorder other than folliculitis or acne On therapy with steroids On therapy with a drug that affects collagen synthesis Positive for HIV or hepatitis Positive urine test for nicotine Positive blood test for antiAZX100 antibodies Participated in another clinical study within 60 days before enrollment Gave blood within 7 days before dosing Gave plasma within 3 days before dosing Tattoo on the shoulder area Applied any prescribed or over the counter agents to the shoulder within 14 days before dosing, or intend to use any scar improving product Visited a tanning salon within 14 days before dosing History of drug addiction or excessive use of alcohol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>AZX100</keyword>
	<keyword>Patient and Observer Scar Assessment Scale</keyword>
	<keyword>POSAS</keyword>
	<keyword>Visual Analog Scale</keyword>
	<keyword>VAS</keyword>
	<keyword>Trocar</keyword>
	<keyword>Scarring</keyword>
	<keyword>Scar reduction</keyword>
	<keyword>Scar prevention</keyword>
</DOC>